Eurofins repurchases 85,000 shares in week of July 20-24

Mon, 27 Jul 2026 11:45:09 -0400

Eurofins Scientific (Paris: ERF) repurchased a total of 85,000 of its own shares between July 20 and July 24, 2026, at a weighted average price of €68.33 per share, according to a regulatory disclosure.

The buybacks were executed across two markets: Euronext Paris (XPAR) and the Cboe Europe exchange (CEUX). Daily transaction volumes ranged from 8,000 to 35,000 shares, with weighted average daily prices ranging from approximately €66.12 to €70.83.

The transactions are reported in compliance with Article 5(1)(b) of EU Market Abuse Regulation No. 596/2014.

Eurofins repurchases 85,000 shares in week of July 20-24

Mon, 27 Jul 2026 11:45:09 -0400

The transactions are reported in compliance with Article 5(1)(b) of EU Market Abuse Regulation No. 596/2014.

Eurofins repurchases 85,000 shares in week of July 20-24

Mon, 27 Jul 2026 11:45:09 -0400

The transactions are reported in compliance with Article 5(1)(b) of EU Market Abuse Regulation No. 596/2014.

Eurofins repurchases 85,000 shares in week of July 20-24

Mon, 27 Jul 2026 11:45:09 -0400

The transactions are reported in compliance with Article 5(1)(b) of EU Market Abuse Regulation No. 596/2014.

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Mon, 27 Jul 2026 11:45:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:

Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Mon, 27 Jul 2026 11:45:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Mon, 27 Jul 2026 11:45:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Mon, 27 Jul 2026 11:45:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Mon, 27 Jul 2026 11:45:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Mon, 27 Jul 2026 11:45:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Mon, 27 Jul 2026 11:45:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Mon, 27 Jul 2026 11:45:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):

Name of the Issuer

Identify code of the Issuer

Transaction day

Identify code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC

Eurofins Scientific: Director/PDMR Shareholding

Fri, 24 Jul 2026 10:57:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Thu, 23 Jul 2026 01:15:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Thu, 23 Jul 2026 01:15:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Thu, 23 Jul 2026 01:15:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Thu, 23 Jul 2026 01:15:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Thu, 23 Jul 2026 01:15:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Thu, 23 Jul 2026 01:15:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Thu, 23 Jul 2026 01:15:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Thu, 23 Jul 2026 01:15:00 -0400

LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026

Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.

Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half progressed, with stronger performance in Life and Consumer & Technology Products Testing. There was no significant growth effect from public working days.

The Adjusted1 EBITDA3 margin18 reached

StreetInsider.com News Articles

Eurofins repurchases 85,000 shares in week of July 20-24

Eurofins repurchases 85,000 shares in week of July 20-24

Eurofins repurchases 85,000 shares in week of July 20-24

Eurofins repurchases 85,000 shares in week of July 20-24

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

Eurofins Scientific: Director/PDMR Shareholding

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth